Skip to main content
# Title Department Research Member Research Year
21 Role of Irreversible Electroporation in Solid Abdominal Tumors Management Department of Radiology Dr. Doaa Mohamed Fouad Mahmoud 2024
22 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2024
23 Factors affecting timing of hypothyroidism following radioactive iodine therapy (RAIT) for patients with Graves' disease: A 12-month observational study Department of Radiotherapy and Nuclear medicine ِAya AbdelBaset Ahmed 2024
24 Value of FoxO3a Gene Expression in Pediatric Acute Lymphoblastic Leukemia Department of Clinical Pathology Madonna Refaat Ayoub 2023
25 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2023
26 Magnesium Sulfate in Pediatric Abdominal Cancer Surgery: Safety and Efficacy in Ultrasound-Guided Transversus Abdominis Plane (US-TAP) Block in Conjugation with Levobupivacaine Department of Anesthesia, Intensive care and Pain management Dr. Fatma Adel Abd Diab. 2023
27 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Abdelrahman Kamel Fathy Mohammed 2023
28 Effect of Transcranial Direct Current Stimulation of Motor Cortex versus Insula Cortex on Chronic Post-Mastectomy Pain: Randomized Sham-Controlled Trial Department of Anesthesia, Intensive care and Pain management Dr. Fatma Adel Abd Diab. 2023
29 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2023
30 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Shimaa Hassan Shabaan Hassan 2023